Form 4: Guardant Health Director Steve Krognes Reports Stock Transaction

Director Steve Krognes of Guardant Health, Inc. reported the acquisition of 154 shares of common stock through the vesting of restricted stock units.

Summary

• Steve Krognes, a director at Guardant Health, Inc., filed a Form 4 indicating a transaction involving the company's stock.
• The transaction occurred on November 30, 2024, and involved the vesting of 154 restricted stock units.
• These units converted into 154 shares of common stock at a price of $0.
• Following this transaction, Krognes directly owns 10,065 shares of common stock and 2,932 restricted stock units.
• The restricted stock units were part of an award granted on August 9, 2022, which vests over time.

Sentiment

Score: 7

Explanation: The document is a routine filing of a stock transaction by a director, which is neither positive nor negative. It is a normal part of corporate governance and transparency.

Positives

• The vesting of restricted stock units indicates that Krognes is meeting the conditions of his compensation package.
• The acquisition of shares at $0 increases Krognes's direct ownership in the company.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It provides transparency into the stock ownership of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• The vesting schedule of the restricted stock units is typical for executive compensation packages, often including a cliff vesting period followed by monthly vesting.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects a change in insider ownership.

Key Dates

Keywords

Guardant Health, Steve Krognes, Form 4, stock transaction, restricted stock units, insider trading, beneficial ownership